Kenneth Frazier

Kenneth C.
Frazier is the founder of Oneten.
Mr. Frazier is Co-Chairman-Leaders Council at Legal Services Corp.
Mr. Frazier is Chairman at MSD Pharma (Singapore) Pte Ltd. since 2021.
Mr. Frazier is Chairman of Health Assurance Initiatives at General Catalyst LLC since 2021.
Mr. Frazier is Chairman at Transcarent, Inc. since 2023.
Mr. Frazier is Director at National Constitution Center.
Mr. Frazier is Director at Catalyst, Inc. since 2020.
Mr. Frazier is Director at Pharmaceutical Research & Manufacturers of America.
Mr. Frazier is Director at Merck Sharp & Dohme Corp.
since 2009.
Mr. Frazier is Independent Director at Eikon Therapeutics, Inc. since 2022.
Mr. Frazier is Director at Weill Cornell Medicine.
Mr. Frazier is Director at Paradigm Health, Inc. Mr. Frazier is Trustee at The Pennsylvania State University since 2013.
Mr. Frazier is Council Member at American Bar Association since 2013.
Mr. Frazier is Member at Council on Foreign Relations, Inc. Mr. Frazier is Member at American Academy of Arts & Sciences.
Mr. Frazier is Member at American Philosophical Society.
Mr. Frazier is Council Member at The American Law Institute since 2013.
Mr. Frazier is Member at The Business Council.
Mr. Frazier is Member at President's Export Council.
Mr. Frazier is Trustee at Cornerstone Christian Academy since 2014.
Former positions include Executive Chairman at Merck & Co., Inc. from 2021 to 2022.
Lead Independent Director at Exxon Mobil Corp.
from 2009 to 2022.
Partner at Drinker Biddle & Reath LLP.
Secretary, Vice President & General Counsel at Astra Merck, Inc. from 1992 to 1994.
Education includes undergraduate degree from The Pennsylvania State University in 1975 and graduate degree from Harvard Law School in 1978.